Health Care Panel
Opportunities in Asia's Growing Health Care Sector
The healthcare market in Asia is dynamic and growing, and China in particular is experiencing rapid change. In addition to the government's healthcare reform plan, its life sciences sector is facing substantial opportunities as well as challenges. The healthcare panel brings together expertise from the medical devices, pharmaceutical, and diagnostics sectors to address the following key issues:
-
What is the changing nature of healthcare coverage and delivery in the Asia-Pac region?
- The focus will be on healthcare reform in China What are some of the opportunities and challenges facing the life-sciences industry in China?
- What are some insights from the medical devices sector?
- What will the impact be of the global structure of the industry, including on the innovation side?
- What are some of the challenges within China? What innovation is taking place in the region?
- What is the state of human resources and flow of talent in and out of China?
- What are some factors that would increase innovation and discovery?
Panelists
George Baeder, Vice President, Monitor Group Asia
George Baeder is Vice President of Monitor Group Asia. George has focused on the region's emerging markets. He has worked across a broad spectrum of industries - including fast moving consumer products, pharmaceuticals, specialty chemicals, oil and gas, natural resources, telecommunications, data processing, consumer electronics and financial services. George also leads Monitor's life sciences practice in the Asia/Pacific region, covering ethical pharmaceuticals, OTC, medical devices and healthcare delivery.
After studying economics and Chinese history in the US and Taiwan, George joined Business International Corp, a New York based business advisory firm in 1973. In 1976 he moved to Hong Kong to build the company's Asian operations. After selling Business International in 1986, George founded the Pacific Rim Consulting Group, a strategy boutique, which he sold to AT Kearney in 1997. Before joining Monitor, George was a Senior Advisor to Asian Capital Partners.
Jimmy Zhang, Senior Vice President, Synergenics, LLC
Dr. Jimmy Zhang is a Senior Vice President at Synergenics, LLC, a professional service and investment company founded and led by Dr. Bill Rutter, one of the founding fathers and pioneers of the biotech industry, and who played a major role in building UCSF and developing the Mission Bay Campus. Synergenics-invested companies cover areas such as therapeutic human monoclonal antibodies, gene therapy, cancer genomics, diabetes, diagnostics, healthcare IT, nutriceutical, vaccine, and biological manufacturing. Jimmy is responsible for the business development of Synergenics and its portfolio companies, and their businesses in China. In addition, Jimmy represented a U.S. public company and led the negotiation of a biotech incubator and industrial real estate investment in a top 3 China city, amounting to $100M.
Jimmy was previously a consultant at McKinsey & Company traveling and working in China, US and Germany. He worked on a wide range of issues and challenges faced by different industries (for example, pharmaceutical, chemicals, steel, investment funds, consumer, energy, government) encompassing, for example, strategic planning, global and country strategies, market entry and expansion strategies, M&A/business development, operations, organizations, marketing etc.
Jimmy received his B.S. in biochemistry from Nanjing University, and Ph.D. in biomedical sciences from the University of Texas Southwestern Medical Center at Dallas, where he worked closely with two Nobel Laureates. While studying his MBA in MIT Sloan, Jimmy was elected as the treasurer of MIT Graduate Student Council. He was also a finalist of the 12th Annual MIT $50K Entrepreneurship Competition (now The MIT $100K Entrepreneurship Competition).
Phoebe Hsueh, Manager, Emerging Markets, Abbott Vascular
As a product manager in the Emerging Markets group at Abbott Vascular, Phoebe is currently focused on developing strategies to help Abbott's cardiovascular devices division maximize growth in China. Previously, Phoebe held several brand marketing and product management roles at two Johnson & Johnson companies where she developed marketing campaigns and launched products for the OneTouch Blood Glucose System and Band-Aid brands. While completing her graduate degree, Phoebe helped the Joslin Diabetes Center launch a new affiliate care model in Dubai. Prior to graduate school, Phoebe worked to attract investment into inner cities at the Initiative for a Competitive Inner City, an economic development think tank founded by Michael Porter. Phoebe also worked at L.E.K. Consulting where she formulated business strategy solutions for various pharmaceutical, biotechnology and diagnostics companies.
Phoebe holds an MBA from Harvard Business School and a BA in Economics with a minor in French from Bates College.
Moderator
Kristiana Raube, Executive Director, Graduate Program in Health Management, Haas School of Business at the University of California-Berkeley 
Kristiana Raube, PhD is an Adjunct Professor at the Haas School of Business and the Executive Director of the Graduate Program in Health Management at the University of California Berkeley, a program that prepares students for leadership roles in all aspects of healthcare, including care delivery and financing, biotechnology and medical devices, information technology, and consulting. Dr. Raube has worked to increase health management capacity through executive education and program development in the US and around the world, including China, India, Vietnam, Romania, Uganda, Lesotho, Togo, and the Demographic Republic of the Congo, among others.
Her research focuses on the delivery and financing of health services and she has evaluated a large number of health programs, including ones focused on physician payment, quality of care, access to care, infant mortality, and community-based health care. Dr. Raube received her doctorate in public policy from the RAND Graduate School of Policy Studies, her masters in public health from UCLA, and her bachelors of arts degree in biology from the University of Colorado.
Recently, Dr. Raube was appointed Executive Director of the International Business Development (IBD) Program also at the Haas School of BUsiness.